Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Child Neurology
How do you counsel on the risks of developing anti-drug antibodies when using intrathecal enzyme replacement therapy for lysosomal storage disorders?
Related Questions
How do you discontinue ketogenic diets previously used as a treatment for epilepsy?
What behavioral interventions have you found most effective for managing self-injurious behavior in autism?
How does a patient’s BASED score after starting infantile spasms therapy guide your treatment plan?
In a neonate with cerebral sinus venous thrombosis who is fluid-limited by renal or cardiac disease, do you recommend hyperhydration before anticoagulation?
When do you consider surgery for patients with Sturge Weber?
Does persistent focal slowing without epileptiform discharges indicate increased seizure risk in patients without significant structural abnormalities?
Would you use bupropion for mood disorder or substance use in an adult patient with previous childhood seizures that resolved?
Is there utility to ordering biochemical screening labs for global developmental delay?
Would you recommend anticoagulation in a pediatric patient with metastases in a dural venous sinus?
How do you use aspirin in pre-symptomatic Sturge Weber patients?
